Publication

A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Anne L. Hotard, Emory UniversityFyza Y. Shaikh, Vanderbilt University School of MedicineSujin Lee, Emory UniversityDan Yan, Emory UniversityMichael N. Teng, University of South Florida College of MedicineRichard Karl Plemper, Emory UniversityJames E. Crowe, Vanderbilt University School of MedicineMartin L Moore, Emory University
Language
  • English
Date
  • 2012-12-05
Publisher
  • Elsevier
Publication Version
Copyright Statement
  • © 2012 Published by Elsevier Inc
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0042-6822
Volume
  • 434
Issue
  • 1
Start Page
  • 129
End Page
  • 136
Grant/Funding Information
  • This work was also supported by the Vanderbilt Medical Scientist Training Program NIGMS/NIH T32 GM007347 and by a grant from the March of Dimes to JEC, as well as NIAID 5R01AI081977 to MNT, and NIH R01 AI071002 to RKP.
  • This work was supported by the following grants awarded to MLM: NIH 1R01AI087798, NIH 1U19AI095227, and a Children’s Healthcare of Atlanta (CHOA) Center for Immunology and Vaccines Pilot Grant.
Abstract
  • We describe the first example of combining bacterial artificial chromosome (BAC) recombination-mediated mutagenesis with reverse genetics for a negative strand RNA virus. A BAC-based respiratory syncytial virus (RSV) rescue system was established. An important advantage of this system is that RSV antigenomic cDNA was stabilized in the BAC vector. The RSV genotype chosen was A2-line19F, a chimeric strain previously shown to recapitulate in mice key features of RSV pathogenesis. We recovered two RSV reporter viruses, one expressing the red fluorescent protein monomeric Katushka 2 (A2-K-line19F) and one expressing Renilla luciferase (A2-RL-line19F). As proof of principle, we efficiently generated a RSV gene deletion mutant (A2-line19FΔNS1/NS2) and a point mutant (A2-K-line19F-I557V) by recombination-mediated BAC mutagenesis. Together with sequence-optimized helper expression plasmids, BAC-RSV is a stable, versatile, and efficient reverse genetics platform for generation of a recombinant Pneumovirus.
Author Notes
  • Correspondence should be addressed to Martin L. Moore, Division of Pediatric Infectious Diseases, Emory University School of Medicine, 2015, Uppergate Dr NE Room 514, Atlanta, GA 30322; Phone: 404-727-9162; Fax: 404-727-9223; Email: martin.moore@emory.edu
Keywords
Research Categories
  • Biology, Virology
  • Biology, Genetics

Tools

Relations

In Collection:

Items